Literature DB >> 4348606

Multiple sclerosis: an immunologic reassessment.

P Y Paterson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4348606     DOI: 10.1016/0021-9681(73)90085-4

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


× No keyword cloud information.
  12 in total

1.  T and B lymphocytes in multiple sclerosis.

Authors:  R P Lisak; A I Levinson; B Zweiman; N I Abdou
Journal:  Clin Exp Immunol       Date:  1975-10       Impact factor: 4.330

Review 2.  Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis.

Authors:  Halina Offner; Sushmita Sinha; Chunhe Wang; Gregory G Burrows; Arthur A Vandenbark
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

Review 3.  The evidence justifying immunosuppression therapy in multiple sclerosis.

Authors:  J Mertin
Journal:  Proc R Soc Med       Date:  1977-12

4.  GPR30 FORMS AN INTEGRAL PART OF E2-PROTECTIVE PATHWAY IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS.

Authors:  Sheetal Bodhankar; Halina Offner
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2011-12

5.  Cyclophosphamide in exacerbations of multiple sclerosis. Therapeutic trial and a strategy for pilot drug studies.

Authors:  D A Drachman; P Y Paterson; R T Schmidt; R F Spehlmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-06       Impact factor: 10.154

6.  Immunologic determinants of experimental neurologic autoimmune disease and approaches to the multiple sclerosis problem.

Authors:  P Y Paterson; R S Fujinami; E D Day; V A Varitek; M D Pescovitz; J Kelly; L Lorand
Journal:  Trans Am Clin Climatol Assoc       Date:  1978

7.  Lymphocytotoxic antibody in multiple sclerosis: activity against T cell subsets and correlation with disease activity.

Authors:  C F Scott; L E Spitler
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

8.  Effect of rat and beta-human interferons on hyperacute experimental allergic encephalomyelitis in rats.

Authors:  F Hertz; R Deghenghi
Journal:  Agents Actions       Date:  1985-07

9.  Chronic relapsing experimental allergic encephalomyelitis: CNS plaque development in unsuppressed and suppressed animals.

Authors:  C S Raine; U Traugott; S H Stone
Journal:  Acta Neuropathol       Date:  1978-08-07       Impact factor: 17.088

10.  Beta-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients.

Authors:  H Ohguro; S Chiba; Y Igarashi; H Matsumoto; T Akino; K Palczewski
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.